Company / Current Assets per Share
Ligand Pharmaceuticals, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$43.56
FY2025
5-year range
$14.01 / $43.56
FY2021-FY2025
Trend
+130.7%
vs FY2024
Sector context
#13 of 210
Health Care
What the data says
Among 210 Health Care companies, Ligand Pharmaceuticals, Inc. is in the top 6% for current assets per share. Improved from $14.01 to $43.56 over the past 2 years.
Based on SEC 10-K filings.
43.56 in FY2025 with a 5-year CAGR of +7.9%. Top quartile in the Health Care sector.
Improved from $14.01 to $43.56 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +40.5%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 210This company $43.56 Sector average $170.65
▼
-74.5% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 130.7% year-over-year.
- Ranks #13 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.56 | +130.7% |
| FY2024 | $18.89 | +34.8% |
| FY2023 | $14.01 | -10.9% |
| FY2022 | $15.72 | -45.6% |
| FY2021 | $28.90 | -2.9% |
| FY2020 | $29.75 | -45.0% |
| FY2019 | $54.11 | +31.5% |
| FY2018 | $41.16 | +263.1% |
| FY2017 | $11.34 | +38.7% |
| FY2016 | $8.17 | -25.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026